Cyclerion Therapeutics Inc. (CYCN)
NASDAQ · Healthcare
Cyclerion Therapeutics Inc. Operating Income 2019–2025
Cyclerion Therapeutics Inc. annual/quarterly operating income history and growth rate from 2019 to 2026. Operating income (EBIT) is profit from core business operations, excluding interest and income taxes. It reflects the efficiency of a company's core operations.
- Cyclerion Therapeutics Inc. operating income for the quarter ending March 31, 2026 was -3.2 M, a 120.25% increase year-over-year.
- Cyclerion Therapeutics Inc. operating income for the twelve months ending March 31, 2026 was -7.3 M, a 27.61% decrease year-over-year.
- Cyclerion Therapeutics Inc. annual operating income for 2025 was -5.0 M, a 37.07% increase from 2024.
- Cyclerion Therapeutics Inc. annual operating income for 2024 was -3.6 M, a 71.99% decrease from 2023.
- Cyclerion Therapeutics Inc. annual operating income for 2023 was -13.0 M, a 30.15% decrease from 2022.
- Cyclerion Therapeutics Inc. annual operating income for 2022 was -18.5 M.
Operating Income
ANNUAL · $B
QUARTERLY · $B
YEAR-OVER-YEAR GROWTH · %
Cyclerion Therapeutics Inc. Operating Income — FAQ
Cyclerion Therapeutics Inc. (CYCN) operating income over the last 7 years — annual and quarterly figures with year-over-year growth and charts.
What is Cyclerion Therapeutics Inc.'s operating income?
Cyclerion Therapeutics Inc. (CYCN) reported operating income of -$5M for fiscal 2025.
Where can I see CYCN's operating income history?
The chart and table above show Cyclerion Therapeutics Inc.'s operating income by year and by quarter, including the growth rate.